First National Corp Abbott Laboratories Transaction History

First National Corp

$418 Million
Q1 2024

A detailed history of First National Corp transactions in Abbott Laboratories stock. As of the latest transaction made, First National Corp holds 11,675 shares of ABT stock, worth $1.19 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

11,675

Previous 11,675 -0.0%

Holding current value

$1.19 Million

Previous $1.29 Million 3.19%

% of portfolio

0.32%

Previous 0.32%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$90.19 - $110.4 $1,533 - $1,876	17 Added 0.15%	11,675 $1.29 Million
Q2 2023 Jul 31, 2023	BUY	$100.78 - $112.29 $2,015 - $2,245	20 Added 0.17%	11,658 $1.27 Million
Q4 2022 Jan 26, 2023	SELL	$95.06 - $111.52 $28,898 - $33,902	-304 Reduced 2.55%	11,638 $0
Q3 2022 Oct 24, 2022	SELL	$96.76 - $112.03 $1,548 - $1,792	-16 Reduced 0.13%	11,942 $1.16 Million
Q2 2022 Jul 18, 2022	BUY	$102.07 - $123.37 $11,635 - $14,064	114 Added 0.96%	11,958 $1.3 Million

Q1 2022 Apr 26, 2022	BUY	$114.02 - $139.04 $2,850 - $3,476	25 Added 0.21%	11,844 $1.4 Million
Q3 2021 Nov 09, 2021	BUY	$116.66 - $129.06 $38,847 - $42,976	333 Added 2.9%	11,819 $1.4 Million
Q2 2021 Jul 30, 2021	BUY	$105.79 - $124.53 $2,856 - $3,362	27 Added 0.24%	11,486 $1.05 Million
Q1 2021 May 10, 2021	BUY	$108.84 - $128.23 $8,163 - $9,617	75 Added 0.66%	11,459 $1.37 Million
Q4 2020 Feb 08, 2021	SELL	$105.0 - $114.42 $10,710 - $11,670	-102 Reduced 0.89%	11,384 $1.25 Million
Q4 2019 Jan 31, 2020	SELL	$78.51 - $87.4 $22,453 - $24,996	-286 Reduced 2.43%	11,486 $998,000
Q2 2019 Jul 30, 2019	SELL	$72.88 - $85.0 $7,288 - $8,500	-100 Reduced 0.84%	11,772 $990,000
Q4 2018 Jun 12, 2019	BUY	$65.56 - $74.27 $778,328 - $881,733	11,872 New	11,872 $859,000

Others Institutions Holding ABT

# of Institutions

3,130

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $179B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Corp , based on Form 13F filings with the SEC.

News

Stay updated on First National Corp with notifications on news.

Account

First National Corp Abbott Laboratories Transaction History